General Information of the Compound
| Compound ID |
CP0439110
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[(1S,2R,3S,4R)-4-[6-(2,2-diphenylethylamino)-2-[2-(1-propan-2-ylimidazol-4-yl)ethylamino]purin-9-yl]-2,3-dihydroxycyclopentyl]-2,2-dimethylpropanamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C37H47N9O3
|
||||||||||||||||||
| Molecular Weight |
665.843
|
||||||||||||||||||
| Canonical SMILES |
CC(C)n1cnc(CCNc2nc(NCC(c3ccccc3)c3ccccc3)c3ncn([C@@H]4C[C@H](NC(=O)C(C)(C)C)[C@@H](O)[C@H]4O)c3n2)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C37H47N9O3/c1-23(2)45-20-26(40-21-45)16-17-38-36-43-33(39-19-27(24-12-8-6-9-13-24)25-14-10-7-11-15-25)30-34(44-36)46(22-41-30)29-18-28(31(47)32(29)48)42-35(49)37(3,4)5/h6-15,20-23,27-29,31-32,47-48H,16-19H2,1-5H3,(H,42,49)(H2,38,39,43,44)/t28-,29+,31+,32-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
UVLGOYYWYHFWSY-XPZSDMQCSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound